Phathom Pharmaceuticals Inc Revenue per Employee (PHAT), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Phathom Pharmaceuticals Inc   (NASDAQ: PHAT)
 

Phathom Pharmaceuticals Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 104.43% in the first quarter 2026, year on year to cumulative value of $205 million, Phathom Pharmaceuticals Inc 's revenue per employee grew on a trailing twelve months basis to $ 552,270, this marks a new company high.
Within the Healthcare sector Employees of 54 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 589, from total ranking in previous quarter at 1643. Phathom Pharmaceuticals Inc has 371 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PHAT Revenue per Employee (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Revenue Change 104.43 % 94.12 % 202.74 % 439.36 % 1391.58 %
Sales per Employee (TTM) $ 552,270 471,995 396,739 307,380 220,644
PHAT's Total Ranking # 589 # 1643 # 89 # 407 # 557
Seq. Revenue Change 1.25 % 16.32 % 25.32 % 38.51 % -3.86 %

PHAT Company Profile >> Back to PHAT Efficiency Comparisons >> Compare PHAT Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 32
Healthcare Sector # 55
Overall Market # 589

Revenue per Employee Statistics
High Average Low
$ 552,270 $ 309,823 $ 70,809
(Mar 31 2026)   (Sep 30 2024)



Financial Statements
Phathom Pharmaceuticals Inc 's Revenue MRQ $ 58 Millions Visit PHAT's Income Statement
Phathom Pharmaceuticals Inc 's Revenues TTM $ 205 Millions Visit PHAT's aggregate revenue growth
What are PHAT's Sales? Visit PHAT's Sales by Segment




Other Ratios
Phathom Pharmaceuticals Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
PHAT's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for PHAT's Competitors
Revenue per Employee for PHAT's Suppliers
Revenue per Employee for PHAT's Customers

You may also want to know
PHAT's Sales Growth Rates PHAT's Pe Price to earnings ratio PHAT's Receivables Turnover Ratio PHAT's Stock Quote
PHAT's Net Income Growth Rates PHAT's Ps Price to Sales ratio PHAT's Sales per Employee PHAT's Asset Turnover Ratio
PHAT's Net Margin PHAT's Pb Price to Book ratio PHAT's Financial Strength Ratios PHAT's Dividend Payout Ratio
Date modified: 2026-08-30T15:00:01+00:00




Companies with similar Revenue per Employee for 12 months ending Mar 31 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Mar 31 2026Number of Employees Mar 31 2026
Ani Pharmaceuticals Inc  952,274.23 $ 923.706  Million 970 
Integrated Biopharma Inc  944,820.00 $ 47.241  Million 50 
Evolus Inc   905,236.53 $ 302.349  Million 334 
Pacira Biosciences inc   886,446.32 $ 734.864  Million 829 
Keenova Therapeutics Plc  883,125.00 $ 1,413.000  Million 1,600 
Nektar Therapeutics  883,063.49 $ 55.633  Million 63 
Merck and Co Inc   876,906.67 $ 65,768.000  Million 75,000 
Arrowhead Pharmaceuticals Inc   874,836.85 $ 622.009  Million 711 
Ardelyx inc   874,599.18 $ 427.679  Million 489 
Lifevantage Corp  868,242.15 $ 193.618  Million 223 
Prothena Corporation Public Limited Company  864,776.12 $ 57.940  Million 67 
Alphatec Holdings Inc   861,301.20 $ 786.368  Million 913 
Lexicon Pharmaceuticals Inc   859,790.12 $ 69.643  Million 81 
The Oncology Institute Inc   851,425.90 $ 545.764  Million 641 
Fortress Biotech Inc   848,217.95 $ 66.161  Million 78 
Pfizer Inc  844,200.00 $ 63,315.000  Million 75,000 
Carlisle Companies Incorporated  843,423.73 $ 4,976.200  Million 5,900 
Ptc Therapeutics inc   834,621.59 $ 827.110  Million 991 
Sanuwave Health Inc   805,963.64 $ 44.328  Million 55 
Xtant Medical Holdings Inc   801,331.13 $ 121.001  Million 151 
Novavax inc   796,178.91 $ 596.338  Million 749 
Marker Therapeutics inc   789,851.20 $ 3.949  Million 5 
Immunocore Holdings Plc  787,809.16 $ 412.812  Million 524 
Adma Biologics Inc   784,800.62 $ 507.766  Million 647 
Axsome Therapeutics Inc   765,660.54 $ 708.236  Million 925 
Alkermes Plc   762,097.56 $ 1,562.300  Million 2,050 
Dyadic International Inc   761,545.80 $ 3.808  Million 5 
Geron Corporation  759,135.66 $ 195.857  Million 258 
Emergent Biosolutions Inc   752,000.00 $ 676.800  Million 900 
Cerus Corporation  749,159.72 $ 215.758  Million 288 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.